These novel medications , Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and possibly related disorders. They all are grouped as GLP-1 receptor stimulators, meaning they to replicate the natural GLP-1 peptide, stimulating metabolic release and suppressing food intake. Although Tirzepatide each one functions so